http://www.fiercepharma.com/pharma/lilly-s-adhd-med-strattera-faces-new-generic-competition-from-teva-and-others?utm_medium=nl&utm_source=internal&mrkid=41785545&mkt_tok=eyJpIjoiWWpGaE1qQTBZMkptTVRReCIsInQiOiJvMElvYVNsOHNHSHlTVFMyNzhtMkI1WEVBSW5xTk0xU08xUnZmYlVmMVk2YkI5bTkzeXlmM3RLOGZpa3NRWVFPcmlPWUhPQ1JpM3VTS2liblF5ZDRQb0NDQUpGdUhEbGcwcVpmaGR6YmtlVEdpRkVrcjEydmg2ODhwaUZsZXROaSJ9

AstraZeneca is notifying physicians and consumers that it is voluntarily recalling one lot of professional (physician) sample bottles containing eight tablets of Brilinta (ticagrelor) 90mg tablets as a precautionary measure. This voluntary recall follows a report that a professional sample…

You’re already fighting the proposed cuts to PACE and Medicaid dispensing fees, but your patients need to understand the detrimental effect these proposals would have on them. Discuss these proposals with your patients to help them understand the harmful consequences…

A civil war has broken out among the most powerful players in the industry, which is scrambling in the face of public anger and legislative efforts to reduce costs. https://www.nytimes.com/2017/05/29/health/drug-lobbyists-battle-cry-over-prices-blame-the-others.html?smprod=nytcore-ipad&smid=nytcore-ipad-share

http://www.fiercepharma.com/pharma/new-fda-commissioner-gottlieb-unveils-price-fighting-strategies?utm_medium=nl&utm_source=internal&mrkid=41785545&mkt_tok=eyJpIjoiTlRKalpUSmxOREEwTW1NNSIsInQiOiJrNW9ncDJJQjZhSUQrSDdFcHA3YWcyd1MwQXQwODA3dmQydDZcL2k5a0hPbkp5cFlFYVhqMzdOWHlWRDQ3Q2R1TGpEXC90NExwQVpQUHBOa3VmdU1Vc3hva0wwaU1UT2F0NlRlNDZQRFpmY25xXC8weHFIcDF6cVZubXdFUGRJdXJWMCJ9

https://blogs.fda.gov/fdavoice/index.php/2017/05/fda-commissioner-asks-staff-for-more-forceful-steps-to-stem-the-opioid-crisis/

Congress will be in recess from May 26-June 5 for the Memorial Day holiday. Many legislators will be in their districts meeting with constituents and attending local events. This is an opportune time to engage your legislators and invite them…

Click on the link below to see the article. A Reality Check on Amazon’s Pharmacy Ambitions 

From left to right..  Police Commissioner Richard Ross, Jr.; Bernie Prazenica, PAL Board Chair and General Manager of WPVI TV/6abc; Mel Brodsky, Rich Ost; Lt. Evelyn Cintron, PAL’s Commanding Officer and Ted Qualli, PAL’s Executive Director. 

Based on new data from two large clinical trials, the U.S. Food and Drug Administration (FDA) has concluded that the type 2 diabetes medicine canagliflozin (Invokana, Invokamet, Invokamet XR) causes an increased risk of leg and foot amputations. We are…

Click the link to see presentation done by PrescribeWellness: https://www.pscp.tv/PrescribeWell/1RDxlZVnkWRGL

http://www.fiercepharma.com/pharma/amid-pricing-scrutiny-drugmakers-team-up-express-scripts-to-find-savings-for-cash-paying?mkt_tok=eyJpIjoiWWpGak1ETmxOamxsTkRVMSIsInQiOiIzK1VGOEY4S1A0UzlzVm1rczM0cmg0cngyemNGbmtUekNRZXJYcW1maXZQbzB0bzE5T1FSQ1BoeFVIRnNHeWYxb0VLa1wvczNBcWVOWlR5ZmhIaHZNUWlCY1kxOFlubXI1SHVoOUVxNTBDcXJDbWpIYklwXC9TaDFzUUtcLzRoZWNmSiJ9&mrkid=41785545&utm_medium=nl&utm_source=internal  

The Pennsylvania House of Representatives passed House Bill 454 today; this bill would require pharmacy technicians to register with the State Board of Pharmacy. The bill now awaits consideration from the Pennsylvania State Senate. You can learn more about this…

NCPA Members—Free Webinar for CE credit on May 10th. Understand the major statutes and regulations impacting pharmacy compliance today. Get Tips to Be Proactively Compliant on a May 10 Webinar (& Earn CE) Over the past several years, government enforcement in…

The employees of Keystone and PARD gave back today by volunteering their time at the Choice Foods pantry at KleinLife on Jamison Avenue in Philadelphia.  Stocking shelves and filling orders gave the team a chance to pay it forward. From…

https://www.linkedin.com/pulse/pet-medication-market-growing-joshua-pirestani?trk=v-feed&lipi=urn%3Ali%3Apage%3Ad_flagship3_detail_base%3B4sEiRQyi%2FPzOR4v46DJsSw%3D%3D  

General Q&A Please click here for more information on the Prescription Drug Monitoring Program.

https://www.bloomberg.com/news/articles/2017-04-26/secret-profit-formulas-at-risk-as-drug-middleman-loses-contract